1. Medicines and Healthcare products Regulatory Agency. MHRA Guideline for the Naming of Medicinal Products and Braille Requirements for Name on Label. June 2019. https://assets.publishing.service.gov.uk/media/5d0cb4dd40f0b620109f090c/MHRA_Guideline_for_the_Naming_of_Medicinal_Products_and_Braille_Requirements_for_Name_on_Label.pdf.
2. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Best Practices in Developing Proprietary Names for Human Prescription Drug Products. Guidance for Industry. December 2020. https://www.fda.gov/media/88496.
3. When I use a word . . . The languages of medicines—trade names, proprietary names, or brand-names
4. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products. Draft Guidance for Industry. December 2020. https://www.fda.gov/media/88496.
5. Kohn LT Corrigan JM Donaldson MS , eds. Committee on the Quality of Health Care in America. To Err Is Human: Building a Safer Health System. Institute of Medicine, National Academy Press, 2000: 136.